ID   Mel-NT7-00
AC   CVCL_UW19
DR   ESTDAB; ESTDAB-124
DR   Wikidata; Q95988642
RX   PubMed=15592718;
CC   HLA typing: A*03:02,03:02; B*51:01:01,51:01:01; C*01:02:01,01:02:01; DPB1*04:01,04:02; DQB1*03:01:01,05:01 (PubMed=15592718).
ST   Source(s): ESTDAB=ESTDAB-124
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D3S1358: 14,16
ST   D5S818: 12,14
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8,12
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
RX   PubMed=15592718; DOI=10.1007/s00262-004-0561-5; PMCID=PMC11032966;
RA   Rodriguez, Teresa
RA   Mendez, Rosa
RA   Roberts, Chrissy H.
RA   Ruiz-Cabello Osuna, Francisco
RA   Dodi, I. Anthony
RA   Lopez-Nevot, Miguel Angel
RA   Paco, Laura
RA   Maleno, Isabel
RA   Marsh, Steven G.E.
RA   Pawelec, Graham
RA   Garrido, Federico
RT   "High frequency of homozygosity of the HLA region in melanoma cell
RT   lines reveals a pattern compatible with extensive loss of
RT   heterozygosity.";
RL   Cancer Immunol. Immunother. 54:141-148(2005).
//